Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
completednot_applicable

Study Comparing the P200TxE and P200DTx

NCT03964831
recruitingnot_applicable

P200TxE Diseased Eye Image Collection

NCT06269666
completednot_applicable

Study Comparing the P200TE and the P200TxE in Glaucoma Patients

NCT03912584

Clinical Trials (3)

Showing 3 of 3 trials
NCT03964831Not Applicable

Study Comparing the P200TxE and P200DTx

Completed
NCT06269666Not Applicable

P200TxE Diseased Eye Image Collection

Recruiting
NCT03912584Not Applicable

Study Comparing the P200TE and the P200TxE in Glaucoma Patients

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3